Billiontoone, Inc. (NASDAQ:BLLN) Given Average Rating of “Moderate Buy” by Analysts

Billiontoone, Inc. (NASDAQ:BLLN) has been given an average recommendation of “Moderate Buy” by the ten brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and six have given a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $135.2857.

Several brokerages have issued reports on BLLN. Stifel Nicolaus began coverage on Billiontoone in a research note on Monday, December 1st. They set a “buy” rating and a $145.00 price objective on the stock. Wall Street Zen upgraded Billiontoone to a “hold” rating in a report on Saturday, November 15th. Piper Sandler reissued an “overweight” rating on shares of Billiontoone in a research report on Wednesday, December 10th. Weiss Ratings initiated coverage on shares of Billiontoone in a report on Tuesday, February 3rd. They issued a “sell (d)” rating for the company. Finally, Zacks Research upgraded shares of Billiontoone to a “hold” rating in a research note on Tuesday, December 2nd.

Billiontoone Stock Performance

Shares of BLLN stock opened at $85.42 on Friday. The business’s fifty day moving average is $89.07. The firm has a market cap of $3.91 billion and a price-to-earnings ratio of 854.20. Billiontoone has a 1-year low of $80.00 and a 1-year high of $138.70.

Billiontoone (NASDAQ:BLLN) last issued its earnings results on Tuesday, December 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.06). The firm had revenue of $83.52 million for the quarter, compared to analyst estimates of $82.86 million.

Institutional Investors Weigh In On Billiontoone

Several institutional investors and hedge funds have recently bought and sold shares of BLLN. Rossby Financial LCC acquired a new position in Billiontoone in the fourth quarter valued at approximately $25,000. Wells Fargo & Company MN bought a new stake in shares of Billiontoone in the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC acquired a new position in Billiontoone during the 4th quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in Billiontoone during the 4th quarter worth $82,000. Finally, Renaissance Capital LLC bought a new position in Billiontoone during the 4th quarter worth $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.